Cargando…
MON-246 Long-Term Impact of Recombinant Follicle Stimulating Hormone Treatment in Five Infants with Hypogonadotropic Hypogonadism
Background Severe congenital hypogonadotropic hypogonadism (CHH) in boys can be diagnosed during the minipuberty of infancy. Combined gonadotrophin treatment at that age is suggested to improve testicular function, yet long-term evidence is lacking. We describe the first long-term follow-up data on...
Autores principales: | Kohva, Ella, Miettinen, Paivi, Hero, Matti, Huopio, Hanna, Raivio, Taneli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550613/ http://dx.doi.org/10.1210/js.2019-MON-246 |
Ejemplares similares
-
Recombinant Human FSH Treatment Outcomes in Five Boys With Severe Congenital Hypogonadotropic Hypogonadism
por: Kohva, Ella, et al.
Publicado: (2018) -
Treatment of gonadotropin deficiency during the first year of life: long-term observation and outcome in five boys
por: Kohva, Ella, et al.
Publicado: (2019) -
Comment on reversal of hypogonadotropic hypogonadism in a Chinese cohort
por: Dwyer, Andrew, et al.
Publicado: (2015) -
Screening for mutations in selected miRNA genes in hypogonadotropic hypogonadism patients
por: Iivonen, Anna-Pauliina, et al.
Publicado: (2019) -
Circulating Liver-enriched Antimicrobial Peptide-2 Decreases During Male Puberty
por: Varimo, Tero, et al.
Publicado: (2022)